Assessment of anticholinergic burden in elderly patients admitted to the hospitals in the Kyrgyz Republic

Zurdinova A.A.; Sharaeva A.T.

doi:https://doi.org/10.17116/medtech20204103155

Zurdinova A.A.

Kyrgyz-Russian Slavic University

Sharaeva A.T.

Kyrgyz-Russian Slavic University

Assessment of anticholinergic burden in elderly patients admitted to the hospitals in the Kyrgyz Republic

Authors:

Zurdinova A.A., Sharaeva A.T.

More about the authors

Journal: Medical Technologies. Assessment and Choice. 2020;(3): 55‑60

DOI: 10.17116/medtech20204103155

Read: 5252 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Zurdinova AA, Sharaeva AT. Assessment of anticholinergic burden in elderly patients admitted to the hospitals in the Kyrgyz Republic. Medical Technologies. Assessment and Choice. 2020;(3):55‑60. (In Russ.)
https://doi.org/10.17116/medtech20204103155

Подписка 2026 Медицинские технологии. Оценка и выбор (Medical Technologies. Assessment and Choice)

Использование инфографики авторами научных работ

Close metadata

OBJECTIVE

To analyze the relationship between anticholinergics intake and anticholinergic cognitive burden in elderly patients with cardiovascular diseases admitted to the hospitals in Bishkek.

MATERIAL AND METHODS

We analyzed 100 prescription sheets, questionnaires of 100 patients on self-assessment, Short Blessed Test (SBT) results. We also estimated the administered drugs using Anticholinergic Cognitive Burden Scale (ACB). It was a cross-sectional study.

RESULTS

Anticholinergic drugs with ACB score 1 result side effects in 23% of cases, score 2 — in 32%, score 3 — in 41%. According to patients’ self-assessment data, the main side effects were constipation, falls, mood disorders, anxiety. SBT also showed an increased risk of side effects and associated cognitive impairment for higher scores.

CONCLUSION

It is necessary to regulate administration of drugs in advanced age patients using clinical guidelines and protocols, to timely train specialists, students and residents in order to reduce anticholinergic burden and associated adverse effects.

Keywords:

anticholinergic drugs

elderly patients

anticholinergic cognitive burden scale

shot blessed test

Authors:

Zurdinova A.A.

Kyrgyz-Russian Slavic University

Sharaeva A.T.

Kyrgyz-Russian Slavic University

Received:

18.04.2020

Accepted:

30.06.2020

Close metadata

References:

Lopez-Alvarez J, Sevilla-Liewellyn-Jones J, Aguera-Prtiz L. Anticholinergic Drugs in Geriatric Psychopharmacology. Frontiers in Neuroscience. Review. 2019;13:1309. https://doi.org/10.3389/fnins.2019.01309
Brombo G, Bianchi L, Maietti E, Malacarne F, Corsonello A, Cherubini A, Ruggiero C, Onder G, Volpato S. Association of Anticholinergic Drug Burden with Cognitive and Functional Decline Over Time in Older Inpatients: Results from the CRIME Project. Drugs and Aging. 2018;35(10):917-924. https://doi.org/10.1007/s40266-018-0584-9
Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, Smithard D, Coulton S, Katona C, Boustani MA, Brayne C. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. Journal of the American Geriatrics Society. 2011;59(8):1477-1483. https://doi.org/10.1111/j.1532-5415.2011.03491.x
Kersten H, Wyller TB. Anticholinergic drug burden in older people’s brain — how well is it measured? Basic and Clinical Pharmacology and Toxicology. 2014;114(2):151-159. https://doi.org/10.1111/bcpt.2014.114.issue-5
Pasina L, Djade CD, Lucca U, Nobili A, Tettamanti M, Franchi C, Salerno F, Corrao S, Marengoni A, Iorio A, Marcucci M, Violi F, Mannucci PM. Association of Anticholinergic Burden with Cognitive and Functional Status in a Cohort of Hospitalized Elderly: Comparison of the Anticholinergic Cognitive Burden Scale and Anticholinergic Risk Scale. Drugs and Aging. 2013;30(2):103-112. https://doi.org/10.1007/s40266-012-0044-x
Salahudden MS, Duffule SB, Nishtala PS. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatrics. 2015;15:31. https://doi.org/10.1186/s12877-015-0029-9
Carnahan RM, Lund BC, Perry PJ, Pollock BG, Culp KR. The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. Journal of Clinical Pharmacology. 2006;46(12):1481-1486. https://doi.org/10.1177/0091270006292126
Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. British Medical Journal. 2006;332(7539):455-459. https://doi.org/10.1136/bmj.38740.439664.de
Han L, Agostini JV, Allore HG. Cumulative anticholinergic exposure is associated with poor memory and executive function in older men. Journal of the American Geriatrics Society. 2008;56(12): 2203-2210. https://doi.org/10.1111/j.1532-5415.2008.02009.x
Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Archives of Internal Medicine. 2008;168(5):508-513. https://doi.org/10.1001/archinternmed.2007.106
Boustani M, Campbell N, Munger S, Maidment I, Fox C. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008;4(3):311-320. https://doi.org/10.2217/1745509X.4.3.311
Ehrt U, Broich K, Larsen JP, Ballard C, Aarsland D. Use of drugs with anticholinergic effect and impact on cognition in Parkinson’s disease: a cohort study. Journal of Neurology, Neurosurgery, and Psychiatry. 2010;81(2):160-165. https://doi.org/10.1136/jnnp.2009.186239
Sittironnarit G, Ames D, Bush AI, Faux N, Flicker L, Foster J, Hilmer S, Lautenschlager NT, Maruff P, Masters CL, Martins RN, Rowe C, Szoeke C, Ellis KA; AIBL Research Group. Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study. Dementia and Geriatric Cognitive Disorders. 2011;31(3):173-178. https://doi.org/10.1159/000325171
Zurdinova AA. Problems of rational medicines use: the situation in Kyrgyzstan. Obzory po klinicheskoj farmakologii i lekarstvennoj terapii. 2018;16(2):57-61. https://doi.org/10.17816/rcf16257-61
Shot Blessed Test. Accessed June 20, 2020. https://health.utah.edu/occupational-recreational-therapies/docs/evaluations-reviews/sbt+.pdf
Sychev DA, Orekhov RE. Anticholinergic burden scale as a method of combating polypharmacy in elderly and senile patients. Klinicheskaya farmakologiya i terapiya. 2016;25(4):81-84. (In Russ.).